Moreover, c-Myc oncoprotein has been shown to be overexpressed in about 50–75% of NSCLC cases [44], and Rapp et al., 2009 reported that this protein was a key metastatic and angiogenesis inducer in an NSCLC mouse model [45]. Here, MYC is linked to non-small cell lung carcinoma.